National Research Corporation (NRC) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $0.88 et chiffre d'affaires de $0.12B pour le prochain exercice fiscal.
